2,6-Dichloro-3-Iodopyridine

We are 2,6-Dichloro-3-Iodopyridine CAS:148493-37-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:  2,6-Dichloro-3-Iodopyridine
CAS.NO:148493-37-2
Synonyms:  2,6-Dichloro-3-Iodopyridine
Pyridine, 2,6-dichloro-3-iodo-
 
Molecular Formula:C5H2Cl2IN
Molecular Weight:273.88700
 
Physical and Chemical Properties:
Density:2.129g/cm3
Boiling point:294.8ºC at 760mmHg
Melting point:/
Flash point:132.1ºC
Index of Refraction:1.652
 
Specification:
Appearance:Light yellow powder
Purity:≥98.0%
 
Packing:25kg/drum, can also be packaged according to customer requirements
Storage:Preserve in well-closed, light-resistant and airtight containers
Application: Pesticide intermediates, dye intermediates, flavor and fragrance intermediates, pharmaceutical intermediates

 2,6-Dichloro-3-Iodopyridine


Related News: In the process of fine chemical industry transfer, intermediates are a very important category, and they are also the main link for China to undertake transfers.56-09-7 Drug manufacturers make medicines by mixing APIs and pharmaceutical excipients.30131-16-9 The company’s iPSC product platform unites stem cell biology and precision genetic engineering to create renewable master engineered iPSC lines that can be repeatedly used to mass produce cancer-fighting immune cells, replacing the high production costs, weeks of manufacturing time, and complex engineering processes required for current-generation CAR T-cell immunotherapies with an off-the-shelf product that has the potential to reach many more patients.Dimethyl nonanedioate CAS:1732-10-1 With nearly 194 billion US dollars of original research medicines facing the expiration of patents in the past five years, more and more domestic companies are focusing on the corresponding characteristic APIs, and have started research and development and production preparations in advance. The scale of production and export of APIs will continue to expand and grow.Advanced clinical trials with the Company’s lead compound, rigosertib, are aimed at what the Company believes are unmet medical needs of patients with MDS.

Related Products
Product Name
(Bromodifluoromethyl)trimethylsilane Cas:115262-01-6 View Details
Ethyl 2-(2-formylaminothiazol-4-yl) glyoxylate View Details
3-(Trifluoromethoxy)benzyl alcohol View Details
2-[2-(2,2,2-Trifluoroethoxy)phenoxy]ethyl bromide manufacturer 4-(dibiphenyl-4-ylamino)phenylboronic acid manufacturer Methyl 3-methylthiopropionate manufacturer 1-Amino-2-(isopropylsulphonyl)benzene manufacturer 2,5-DICHLOROFLUOROBENZENE manufacturer